openPR Logo
Press release

Global BCG Vaccine Market Surges Amid Rising Tuberculosis Concerns and Expanding Immunization Programs 2025 | Top key players - Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory.

06-13-2025 09:43 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

BCG Vaccine Market

BCG Vaccine Market

The BCG Vaccine Market is expected to grow at a CAGR of 4.8% during the forecast period 2024-2031.

The BCG Vaccine Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/bcg-vaccine-market?sz

The BCG Vaccine Market refers to the global industry focused on the production, distribution, and sales of Bacillus Calmette-Guérin (BCG) vaccines, primarily used for tuberculosis (TB) prevention. This market encompasses pharmaceutical companies, healthcare providers, and government agencies working to control TB, especially in regions with high prevalence, while also addressing bladder cancer treatment in certain cases.

Major players in the BCG Vaccine Market

The prominent players in BCG Vaccine market research report are: Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotech Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Key Development

In January 2021, Merck announced the construction of a new manufacturing facility in the United States to expand production capacity for TICE® BCG, a vaccine used primarily in bladder cancer treatment.

In July 2020, the Serum Institute of India initiated a Phase III clinical trial for the BCG vaccine candidate VPM1002. The trial aims to assess the vaccine's potential to reduce infection rates and severe COVID-19 outcomes in high-risk elderly populations.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/bcg-vaccine-market

Market Segments

By Product: Immune BCG, Therapy BCG.

By Demographics: Pediatrics (0-18 Years), Adults (19-35 Years).

By Application: Hospitals, Clinics.

The BCG Vaccine industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global BCG Vaccine Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay ahead with data-driven strategies, competitive analysis, and future outlook.
👉 Get the Extensive Full Report Now: https://www.datamintelligence.com/buy-now-page?report=bcg-vaccine-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global BCG Vaccine Market Surges Amid Rising Tuberculosis Concerns and Expanding Immunization Programs 2025 | Top key players - Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory. here

News-ID: 4065489 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for BCG

BCG Vaccine Market May See Big Move | Japan BCG Laboratory, GSK, GreenSignal Bio …
HTF MI just released the Global BCG Vaccine Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major Giants in BCG Vaccine Market are: Merck & Co., Sanofi, Serum
Global BCG Tuberculosis Vaccine Market An Overview | Japan BCG Laboratory, China …
Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Global BCG Tuberculosis Vaccine Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition. Access the Comprehensive PDF Market Research Analysis Report Here:​​​​​​​ https://www.astuteanalytica.com/request-sample/bcg-tuberculosis-vaccine-market The Global BCG Tuberculosis Vaccine Market was valued at US$ 63.58
Increasing Demand For Therapeutic BCG Vaccines Drives Market Growth - Merck & Co …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Therapeutic BCG Vaccines Market Size, Growth Rate, And Forecast The global therapeutic BCG vaccines market size is expected to grow from $50.73 billion in 2022 to $53.18 billion in 2023 at a compound annual growth rate (CAGR) of 4.82%. The Russia-Ukraine war disrupted the chances of global economic
BCG Vaccine Market Swot Analysis by key players Merck, Sanofi Pasteur, Japan BCG …
BCG Vaccine Market Status and Trend Analysis 2017-2026 (COVID-19 Version) is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the BCG Vaccine Market. Some of the key players profiled in the study are Merck, Sanofi Pasteur,
BCG Vaccine Market: Development Factors and Investment Analysis by Leading Manuf …
LOS ANGELES, United States 2020: This BCG Vaccine market report work with respect to opportunities, challenges, drivers, market structures, and competitive landscape for the clients. The report is a complete overview of the market, covering various aspects including product definition, market segmentation based on various parameters, and the prevailing vendor landscape. The report is helpful to present you better solutions in terms of product trends, future products, marketing strategy, future
BCG Vaccine Booming Segments; Investors Seeking Growth | Sanofi Pasteur, Japan B …
Latest Research Study on Global BCG VaccineMarket published by AMA, offers a detailed overview of the factors influencing the global business scope.Global BCG Vaccine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Global BCG Vaccine.This Report also covers the emerging player's